Basal cell and squamous cell skin cancers

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 5, Issue 5, 2007, Pages 506-529

  Miller, Stanley J ^a   Alam, Murad ^b   Andersen, James ^c   Berg, Daniel ^d   Bichakjian, Christopher K ^e   Bowen, Glen ^f   Cheney, Richard T ^g   Glass, Frank ^h   Grekin, Roy C ⁱ   Grichnik, James M ^j   Kessinger, Anne ^k   Lee, Nancy Y ^l   Lessin, Stuart ^m   Lydiatt, Daniel D ^k   Margolis, Lawrence W ⁱ   Michalski, Jeffrey ⁿ   Nehal, Kishwer S ^l   Nghiem, Paul ^o   Oseroff, Allan R ^g   Rosenberg, E William ^p   Shaha, Ashok R ^l   Siegle, Ronald J ^q   Urist, Marshall M ^r   more..

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c City of Hope Cancer Center   (United States)

^d SEATTLE CANCER CARE ALLIANCE   (United States)

^e UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^f UNIVERSITY OF UTAH   (United States)

^g ROSWELL PARK CANCER INSTITUTE   (United States)

^h H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j DUKE CANCER INSTITUTE   (United States)

^k NEBRASKA MEDICAL CENTER   (United States)

^l MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^m FOX CHASE CANCER CENTER   (United States)

ⁿ BARNES JEWISH HOSPITAL   (United States)

^o MASSACHUSETTS GENERAL HOSPITAL   (United States)

^p UNIVERSITY OF TENNESSEE CANCER INSTITUTE   (United States)

^q OHIO STATE UNIVERSITY   (United States)

^r UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

more..

Author keywords

Basosquamous carcinoma; Bowen's disease; NCCN clinical practice guidelines in oncology; Non melanoma skin cancers; Precancerous lesions; Skin carcinoma; Sunlight and cancer

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; ETRETIN; FLUOROURACIL; GEFITINIB; IMIQUIMOD; ISOTRETINOIN; PHOTOFRIN; RETINOID;

ACTINIC KERATOSIS; ADOLESCENT HEALTH; AGE DISTRIBUTION; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CHEMOSURGERY; CHILDHOOD CANCER; CLINICAL TRIAL; CRYOTHERAPY; DESICCATION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; METASTASIS; PATIENT EDUCATION; PHOTODYNAMIC THERAPY; PRACTICE GUIDELINE; PRECANCER; REVIEW; SKIN ABRASION; SKIN BIOPSY; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TERATOGENICITY;

EID: 34249299746     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2007.0045     Document Type: Review

References (116)

1. Wong CS, Strange RC, Lear JT. Basal cell carcinoma. BMJ 2003;327:794-798.
2. Alam M, Ratner D. Cutaneous squamous cell carcinoma. N Engl J Med 2001;344:975-983.
3. American Cancer Society. Cancer Facts & Figures, 2007. Available at: http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf. Accessed March 19, 2007.
4. Christenson LJ, Borrowman TA, Vachon CM, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 2005;294:681-690.
5. Preston DS, Stern RS. Nonmelanoma cancers of the skin. N Engl J Med 1992;327:1649-1662.
6. Weinstock MA. Epidemiology of ultraviolet radiation. In: Miller SJ, Maloney ME, eds. Cutaneous Oncology: Pathophysiology, Diagnosis, and Management. Malden, MA: Blackwell Scientific Publications Ltd.; 1998;121-128.
7. Perkins JL, Liu Y, Mitby PA, et al. Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2005;23: 3733-3741.
8. Miller SJ, Moresi JM. Actinic keratosis, basal cell carcinoma and squamous cell carcinoma. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. London: Mosby; 2003:1676-1696.
9. Jorizzo JL, Carney PS, Ko WT, et al. Treatment options in the management of actinic keratosis. Cutis 2004;74(6 suppl):9-17.
10. Cohen PR. Bowen's disease: squamous cell carcinoma in situ. Am Fam Physician 1991;44:1325-1329.
11. Rhodes AR. Public education and cancer of the skin. What do people need to know about melanoma and nonmelanoma skin cancer? Cancer 1995;75(suppl 2):613-636.
12. Clowers-Webb HE, Christenson LJ, Phillips PK, et al. Educational outcomes regarding skin cancer in organ transplant recipients: randomized intervention of intensive vs standard education. Arch Dermatol 2006;142:712-718.
13. Gailani MR, Bale AE. Developmental genes and cancer: role of patched in basal cell carcinoma of the skin. J Natl Cancer Inst 1997;89:1103-1109.
14. Brash DE, Rudolph JA, Simon JA, et al. A role for sunlight in skin cancer: UV induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A 1991;88:10124-10128.
15. Nagano T, Ueda M, Ichihashi M. Expression of p53 protein is an early event in ultraviolet light-induced cutaneous squamous cell carcinogenesis. Arch Dermatol 1993;129:1157-1161.
16. Bale AE. Molecular genetics (basal cell carcinoma). In: Miller SJ, Maloney ME, eds. Cutaneous Oncology: Pathophysiology, Diagnosis, and Management. Malden, MA: Blackwell Scientific Publications Ltd.; 1998:586-591.
17. Rees JL. Molecular biology (squamous cell carcinoma). In: Miller SJ, Maloney ME, eds. Cutaneous Oncology: Pathophysiology, Diagnosis, and Management. Malden, MA: Blackwell Scientific Publications Ltd.; 1998:353-360.
18. Cobb MW. Skin cancer in the immunosuppressed host. In: Miller SJ, Maloney ME, eds. Cutaneous Oncology: Pathophysiology, Diagnosis, and Management. Malden, MA: Blackwell Scientific Publications Ltd.; 1998:51-60.
19. McGregor JM, Hawk JLM. Genetic syndromes predisposing to skin cancer development. In: Miller SJ, Maloney ME, eds. Cutaneous Oncology: Pathophysiology, Diagnosis, and Management. Malden, MA: Blackwell Scientific Publications Ltd.; 1998:158-168.
20. Greene FL, Page DL, Fleming ID, et al., eds. AJCC Cancer Staging Manual, Sixth edition. New York: Springer-Verlag; 2002:203-204.
21. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992;26:976-990.
22. Boeta-Angeles L, Bennett RG. Features associated with recurrence. In: Miller SJ, Maloney ME, eds. Cutaneous Oncology: Pathophysiology, Diagnosis, and Management. Malden, MA: Blackwell Scientific Publications Ltd.; 1998:646-656.
23. Haas AF. Features associated with metastasis. In: Miller SJ, Maloney ME, eds. Cutaneous Oncology: Pathophysiology, Diagnosis, and Management. Malden, MA: Blackwell Scientific Publications Ltd.; 1998:500-505.
24. Swanson NA, Johnson TM. Management of basal and squamous cell carcinoma. In: Cummings CW, ed. Otolaryngology-Head and Neck Surgery. St. Louis: Mosby; 1998: 486-500.
25. Swanson NA. Mohs surgery. Technique, indications, applications, and the future. Arch Dermatol 1983;119:761-773.
26. Clayman GL, Lee JJ, Holsinger FC, et al. Mortality risk from squamous cell skin cancer. J Clin Oncol 2005;23:759-765.
27. Silverman MK, Kopf AW, Grin CM, et al. Recurrence rates of treated basal cell carcinomas. Part I: Overview. J Dermatol Surg Oncol 1991;17:713-718.
28. Texas Medical Association. Medicare Part B Newsletter No. 156, February 6, 1998. Available at http://www.texmed.org/Template.aspx?id=2551. Accessed March 19, 2007.
29. Rowe DE, Carroll RJ, Day CL Jr. Long term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989;15: 315-328.
30. Rowe DE, Carroll RJ, Day CL Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989;15:424-431.
31. Hoxtell EO, Mandel JS, Murray SS, et al. Incidence of skin carcinoma after renal transplantation. Arch Dermatol 1977;113:436-438.
32. Gupta AK, Cardella CJ, Haberman HF. Cutaneous malignant neoplasms in patients with renal transplants. Arch Dermatol 1986;122:1288-1293.
33. Stern RS, Lange R. Nonmelanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol 1988;91:120-124.
34. Stern RS, Liebman EJ, Vakeva L. Oral psoralen and ultraviolet A light (PUVA) treatment of psoriasis and persistent risk of non-melanoma skin cancer: PUVA follow-up study. J Natl Cancer Inst 1998;90:1278-1284.
35. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003;348:1681-1691.
36. Penn I. Skin disorders in organ transplant recipients: external anogenital lesions. Arch Dermatol 1997;133:221-223.
37. Miller SJ. Biology of basal cell carcinoma (Part II). J Am Acad Dermatol 1991;24:161-175.
38. Brodland DG. Features associated with metastasis. In: Miller SJ, Maloney ME, eds. Cutaneous Oncology: Pathophysiology, Diagnosis, and Management. Malden, MA: Blackwell Scientific Publications Ltd.; 1998:657-663.
39. Pack GT, Davis J. Radiation cancer of the skin. Radiology 1965;84:436-442.
40. Martin H, Strong E, Spiro RH. Radiation-induced skin cancer of the head and neck. Cancer 1970;25:61-71.
41. Edwards MJ, Hirsch RM, Broadwater JR, et al. Squamous cell carcinoma arising in previously burned or irradiated skin. Arch Surg 1989;124:115-117.
42. Clayman GL, Lee JJ, Holsinger FC, et al. Mortality risk from squamous cell skin cancer. J Clin Oncol 2005;23:759-765.
43. Galloway TJ, Morris CG, Mancuso AA, et al. Impact of radiographic findings on prognosis for skin carcinoma with clinical perineural invasion. Cancer 2005;103:1254-1257.
44. Broders AC. Squamous-cell epirhelioma of the lip. A study of 537 cases. JAMA 1920;74:656-669.
45. Salasche SJ. Features associated with recurrence. In: Miller SJ, Maloney ME, eds. Cutaneous Oncology: Pathophysiology, Diagnosis, and Management. Malden, MA: Blackwell Scientific Publications Ltd.; 1998:494-499.
46. Leffell DJ, Headington JT, Wong DS, et al. Aggressive-growth basal cell carcinoma in young adults. Arch Dermatol 1991;127: 1663-1667.
47. Dinehart SM, Dodge R, Stanley WE, et al. Basal cell carcinoma treated with Mohs surgery. A comparison of 54 younger patients with 1050 older patients. J Dermatol Surg Oncol 1992;18:560-566.
48. Cox NH. Basal cell carcinoma in young adults. Br J Dermatol 1992;127:26-29.
49. Robins P, Albom MJ. Recurrent basal cell carcinomas in young women. J Dermatol Surg Oncol 1975;1:49-51.
50. Roudier-Pujol C, Auperin A, Nguyen T, et al. Basal cell carcinoma in young adults: not more aggressive rhan in older patients. Dermatology 1999;199:119-123.
51. Milroy CJ, Horlock N, Wilson GD, Sanders R. Aggressive basal cell carcinoma in young patients: fact or fiction? Br J Plast Surg 2000;53:393-396.
52. Lowe LL. Histology. In: Miller SJ, Maloney ME, eds. Cutaneous Oncology: Pathophysiology, Diagnosis, and Management. Malden, MA: Blackwell Scientific Publications Ltd.; 1998:633-645.
53. Maloney ME, Miller SJ. Aggressive vs nonaggressive subtypes (basal cell carcinoma). In: Miller SJ, Maloney ME, eds. Cutaneous Oncology: Pathophysiology, Diagnosis, and Management. Malden, MA: Blackwell Scientific Publications Ltd.; 1998:609-613.
54. Borel DM. Cutaneous basosquamous carcinoma. Review of the literature and report of 35 cases. Arch Pathol 1973;95:293-297.
55. Schuller DE, Berg JW, Sherman G, Krause CJ. Cutaneous basosquamous carcinoma of the head and neck: a comparative analysis. Otolaryngol Head Neck Surg 1979;87:420-427.
56. Martin RC II, Edwards MJ, Cawte TG, et al. Basosquamous carcinoma: analysis of prognostic factors influencing recurrence. Cancer 2000;88:1365-1369.
57. Fitzpatrick PJ, Harwood AA. Acute epithelioma-an aggressive squamous cell carcinoma of the skin. Am J Clin Oncol 1985;8: 468-471.
58. Johnson TM, Rowe DE, Nelson BR, Swanson NA. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol 1992;26:467-484.
59. Nappi O, Pettinato G, Wick MR. Adenoid (acantholytic) squamous cell carcinoma of the skin. J Cutan Pathol 1989;16:114-121.
60. Banks ER, Cooper PH. Adenosquamous carcinoma of the skin: a report of 10 cases. J Cutan Pathol 1991;18:227-234.
61. Barr RJ. Classification of cutaneous squamous cell carcinoma. J Cutan Pathol 1991;18:225-226.
62. Breuninger H, Schaumburg-Lever G, Holzschuh J, Horny HP. Desmoplastic squamous cell carcinoma of skin and vermilion surface: a highly malignant subtype of skin cancer. Cancer 1997;79:915-919.
63. Goepfert H, Dichtel WJ, Medina JE, et al. Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg 1984;148:542-547.
64. Otley CC, Stasko T, Tope WD, Lebwohl M. Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects. Dermatol Surg 2006;32: 562-568.
65. Chen K, Craig JC, Shumack S. Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials. Br J Dermatol 2005;152: 518-523.
66. Kovach BT, Murphy G, Otley CC, et al. Oral retinoids for chemoprevention of skin cancers in organ transplant recipients: results of a survey. Transplant Proc 2006;38:1366-1368.
67. Marghoob AA, Slade J, Salopek TG, et al. Basal cell and squamous cell carcinomas are important risk factors for cutaneous malignant melanoma. Screening implications. Cancer 1995;75:707-714.
68. Levi F, LaVecchia C, Te VC, et al. Incidence of invasive cancers following basal cell skin cancer. Am J Epidemiol 1998;147:722-726.
69. Bath FJ, Bong J, Perkins W, et al. Interventions for basal cell carcinoma of the skin. Cochrane Database Syst Rev 2003;4:CD003412
70. Gupta AK, Davey V, Mcphail H. Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: critical review and meta-analysis of efficacy studies. J Cutan Med Surg 2005;9:209-214-
71. Hadley G, Derry S, Moore RA. Imiquimod for actinic keratosis: systematic review and meta-analysis. J Invest Dermatol 2006;126: 1251-1255.
72. Del Rosso J et al. An investigator-blinded assessment comparing the tolerability of imiquimod 5% cream and topical 5-fluorouracil cream in the treatment of AK [abstract]. J Am Acad Dermatol 2006;54: Abstract P2417.
73. Tanghetti E. Efficacy and tolerability of 5% 5-fluorouracil cream and imiquimod 5% cream in the management of actinic keratoses [abstract]. J Am Acad Dermatol 2006;54: Abstract P2421.
74. Siddiqui MA, Perry CM, Scott LJ. Topical methyl aminolevulinate. Am J Clin Dermatol 2004;5:127-137.
75. Pariser DM, Lowe NJ, Stewart DM, et al. Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial. J Am Acad Dermatol 2003;48:227-232.
76. Morton C, Horn M, Leman J, et al. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or fluorouracil for treatment of squamous cell carcinoma in situ: results of a multicenter randomized trial. Arch Dermatol 2006;142:729-735.
77. Silverman MK, Kopf AW, Grin CM, et al. Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation. J Dermatol Surg Oncol 1991;17:720-726.
78. Wolf DJ, Zitelli J A. Surgical margins for basal cell carcinoma. Arch Dermatol 1987;123:340-344.
79. Brodland DG, Zitelli JA. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992;27: 241-248.
80. Pennington BE, Leffell DJ. Mohs micrographic surgery: established uses and emerging trends. Oncology 2005;19:1165-1171.
81. Freeman RG, Knox JM, Heaton CL. The treatment of skin cancer. A statistical study of 1,341 skin tumors comparing results obtained with irradiation, surgery, and curettage followed by electrodesiccation. Cancer 1964;17:535-538.
82. Stoll HL, Milgrom H, Traenkle HL. Results of roentgen therapy of carcinoma of the nose. Arch Dermatol 1964;90:577-580.
83. Traenkle HL, Stoll HL, Lonkar A. Results of roentgen therapy of carcinoma of the lip. Arch Dermatol 1964;90:488-489.
84. Collin JR. Basal cell carcinoma in the eyelid region. Br J Ophthalmol 1976;60:806-809.
85. Avila J, Bosch A, Aristizabal S, et al. Carcinoma of the pinna. Cancer 1977;40:2891-2895.
86. Fischbach AJ, Sause WT, Plenk HP. Radiation therapy for skin cancer. West J Med 1980;133:379-382.
87. Robins P, Rodriguez-Sains R, Rabinovitz H, et al. Mohs surgery for periocular basal cell carcinomas. J Dermatol Surg Oncol 1985;11: 1203-1207.
88. Mendenhall WM, Parsons JT, Mendenhall NP, et al. T2-T4 carcinoma of the skin of the head and neck treated with radical irradiation. J Radiat Oncol Biol Phys 1987;13:975-981.
89. Petrovich Z, Kuisk H, Langholz B, et al. Treatment results and patterns of failure in 646 patients with carcinoma of the eyelids, pinna, and nose. Am J Surg 1987;154:447-450.
90. Petrovich Z, Parker RG, Luxton G, et al. Carcinoma of the lip and selected sites of head and neck skin. A clinical study of 896 patients. Radiother Oncol 1987;8:11-17.
91. Petrovich Z, Kuisk H, Langholz B, et al. Treatment of carcinoma of the skin with bone and/or cartilage involvement. Am J Clin Oncol 1988;11:110-113.
92. Mazeron JJ, Chassagne D, Crook J, et al. Radiation therapy of carcinomas of the skin of nose and nasal vestibule: a report of 1676 cases by the Groupe Europeen de Curietherapie. Radiother Oncol 1988;13:165-173.
93. Lovett RD, Perez CA, Shapiro SJ, et al. External irradiation of epithelial skin cancer. Int J Radiat Oncol Biol Phys 1990;19:235-242.
94. Smith SP, Foley EH, Grande DJ. Use of Mohs micrographic surgery to establish quantitative proof of heightened tumor spread in basal cell carcinoma recurrent following radiotherapy. J Dermatol Surg Oncol 1990;16:1012-1016.
95. Smith SP, Grande DJ. Basal cell carcinoma recurring after radiotherapy: a unique, difficult treatment subclass of recurrent basal cell carcinoma. J Dermatol Surg Oncol 1991;17:26-30.
96. Wilder RB, Kittelson JM, Shimm DS. Basal cell carcinoma treated with radiation therapy. Cancer 1991;68:2134-2137.
97. Wilder RB, Shimm DS, Kittelson JM, et al. Recurrent basal cell carcinoma treated with radiation therapy. Arch Dermatol 1991;127: 1668-1672.
98. Silverman MK, Kopf AW, Bart RS, et al. Recurrence rates of treated basal cell carcinomas. Part 3: surgical excision. J Dermatol Surg Oncol 1992;18:471-476.
99. Silverman MK, Kopf AW, Grin CM, et al. Recurrence rates of treated basal cell carcinomas. Part 4: x-ray therapy. J Dermatol Surg Oncol 1992;18:549-554.
100. Barrett TL, Greenway HT, Massullo V, et al. Treatment of basal cell carcinoma and squamous cell carcinoma with perineural invasion. Adv Dermatol 1993;8:277-305.
101. Boothman DA, Majmudar G, Johnson T. Immediate x-ray-inducible responses from mammalian cells. Radiat Res 1994;138(suppl 1):S44-46.
102. Childers BJ, Goldwyn RM, Ramos D, et al. Long-term results of irradiation for basal cell carcinoma of the skin of the nose. Plast Reconstr Surg 1994;93:1169-1173.
103. Chao CK, Gerber RM, Perez CA. Reirradiation of recurrent skin cancer of the face. A successful salvage modality. Cancer 1995;75: 2351-2355.
104. Fitzpatrick PJ. Organ and functional preservation in the management of cancers of the eye and eyelid. Cancer Invest 1995;13:66-74.
105. Avril MF, Auperin A, Margulis A, et al. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 1997;76:100-106.
106. Lukas VanderSpek LA, Pond G, Wells W, Tsang R. Radiation therapy for Bowen's disease of the skin. Int J Radiation Oncol Biol Phys 2005;63:505-510.
107. Zeitouni N, Oseroff A, Shieh S. Photodynamic therapy for non-melanoma skin cancers. Current review and update. Mol Immunol 2003;39:1133-1136.
108. Marmur ES, Schmults CD, Goldberg DJ. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg 2004;30:264-271.
109. Oldfield V, Keating GM, Perry CM. Imiquimod: in superficial basal cell carcinoma. Am J Clin Dermatol 2005;6:195-200.
110. Patel GK, Goodwin R, Chawla M, et al. Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen's disease): a randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol 2006;54:1025-1032.
111. ClinicalTrials.gov. Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer. Available at: http://clinicaltrials.gov/ ct/gui/show/NCT00066872;jsessionid=33613C762E6E2B6603F930AD756C17DF?order=45. Accessed March 6, 2007.
112. ClinicalTrials.gov. Photodynamic Therapy With or Without Methyl-5-Aminolevulinate in Treating Patients with Basal Cell Skin Cancer. Available at: http://clinicaltrials.gov/show/NCT00022503. Accessed March 6, 2007.
113. Robinson JK. Follow-up and prevention. In: Miller SJ, Maloney ME, eds. Cutaneous Oncology: Pathophysiology, Diagnosis, and Management. Malden, MA: Blackwell Scientific Publications Ltd.; 1998:695-698.
114. Shin DM, Maloney ME, Lippman SM. Follow-up and prevention. In: Miller SJ, Maloney ME, eds. Cutaneous Oncology: Pathophysiology, Diagnosis, and Management. Malden, MA: Blackwell Scientific Publications Ltd.; 1998;565-570.
115. ClinicalTrials.gov. ZD1839 (Iressa) for Recurrent or Metastatic Squamous Cell Carcinoma of the Skin. Available at: http://clinicaltrials.gov/ct/show/ NCT00054691;jsessionid=59AE9916147C658245BF3684ABFCA3D5?order=20. Accessed March 6, 2007.
116. ClinicalTrials.gov. Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer. Available at: http://www.clinicaltrials.gov/ct/show/NCT00126555? order=1. Accessed March 6, 2007.